Clinical Trials Browser

INDUSTRY × Esophageal Neoplasms × Epirubicin × Clear all

NCT00215644 2018-11-02

MATRIX EG

Phase 2 Completed

72 enrolled 7 charts

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00719550 2013-12-05

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Phase 1/2 Completed

Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms